Acute Sore Throat Pain Study

Analgesic Profile of 3 New Ibuprofen Lozenges (V0498TA01A 15 mg, 25 mg, 35 mg) After Single Administration in Acute Sore Throat Pain

"Sore throat is one of the most common complaints encountered in clinical practice. And in 65% of cases, the infection is thought to be viral in nature.

The aim of this study is to evaluate the analgesic profile of 3 Ibuprofen lozenges after single administration in acute sore throat pain."

Inclusion Criteria:

• male or female patients 18 years and older
• patients with a sore throat associated or not with an Upper Respiratory Tract Infection ≥ 24 hours and ≤ 5 days duration, in the absence of Streptococcus group A

Exclusion Criteria:

• patients with hypersensitivity to Ibuprofen or other NSAIDs or the excipients.
• patients having used analgesics or antiseptics or any topical throat treatment or any local medication containing a local oral anaesthetic within 6 hours before study entry and who use analgesics more than ≥ 3 times per week.
• patients having used any anti inflammatory treatment or any long-acting or slow release analgesics within 12 hours before study entry
• patients having taken antibiotics within 14 days before study entry.